bpc 157 acl repair for tendon and ligament injury healing What is BPC-157 and How

This personalization accounts for the relationship between body mass and peptide distribution

Existing data provides some insights into the safety profile of BPC 157: General Safety : Animal studies generally affirm that BPC 157 is well-tolerated with minimal adverse effects at therapeutic doses

The shorthand 5-Amino-1MQ describes a quinolinium scaffold bearing a methyl substituent at the ring nitrogen (1-methylquinolinium) and an amino group at the 5-position

Bottom Line BPC-157 is an unapproved drug

Reported oral bioavailability around 38 percent and a half-life of roughly 6.9 hours oral / 3.8 hours IV in rats

It is hereby understood that the information provided does not replace medical advice provided by your healthcare provider